Donor-Derived Fc Gamma Receptor Polymorphisms and Infectious Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors

Ayano Shirai, Hirotaro Sakaki, Misuzu Sato, Kazuki Nagao, Hidenori Hayashi, Natsuki Kawamata, Kai Kuroiwa, Hinako Narita, Reiko Okamura, Shotaro Shimada, Megumi Watanuki, Nana Arai, Kouji Yanagisawa, Keiichi Iezumi, Norimichi Hattori

Published in

Transplantation proceedings. Oct 27, 2026. Epub Oct 27, 2026.

Abstract

Delayed immune reconstitution after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a major risk factor for infectious complications. Donor-derived genetic variation in immunoregulatory pathways may influence post-transplant immune recovery and susceptibility to infections.
We analyzed a cohort of 97 adult patients who underwent allo-HSCT. Donor-derived single nucleotide polymorphisms (SNPs) in FCGR2A (rs1801274), FCGR3A (rs396991), FOXP3 (rs3761548), and IL10 (rs1800871) were genotyped using samples demonstrating complete donor chimerism. Associations with engraftment kinetics, immune reconstitution, and infectious complications were evaluated.
Donor-derived IL10-819 non-T/T genotype was associated with earlier neutrophil engraftment and significantly reduced early recovery of total lymphocytes, CD4⁺ T cells, CD8⁺ T cells, and B cells. However, this genotype was not associated with an increased incidence of bacterial, viral, or fungal infections. In contrast, recipients of grafts from donors with the FCGR3A-158 non-F/F genotype exhibited a significantly higher cumulative incidence of fungal infections compared with those receiving grafts from donors with the F/F genotype. No consistent associations were observed between other SNPs and infectious outcomes.
Donor-derived genetic variation in FCGR3A may be associated with an increased risk of fungal infections after allo-HSCT, whereas IL10 polymorphisms appear to influence early immune reconstitution without translating into clinically overt infectious susceptibility. Given the exploration and limited sample size of this study, these findings should be considered hypothesis-generating and warrant validation in larger cohorts.

PMID:
42934077
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.